LSV Asset Management’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $292K | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $673K | Hold |
|
|||||
|
2023
Q1 | $812K | Sell |
|
|||||
|
2022
Q4 | $877K | Hold |
|
|||||
|
2022
Q3 | $833K | Sell |
|
|||||
|
2022
Q2 | $801K | Hold |
|
|||||
|
2022
Q1 | $895K | Sell |
|
|||||
|
2021
Q4 | $828K | Sell |
|
|||||
|
2021
Q3 | $992K | Sell |
|
|||||
|
2021
Q2 | $5.96M | Sell |
|
|||||
|
2021
Q1 | $26.8M | Buy |
|
|||||
|
2020
Q4 | $25.7M | Buy |
|
|||||
|
2020
Q3 | $16.9M | Buy |
|
|||||
|
2020
Q2 | $16.5M | Sell |
|
|||||
|
2020
Q1 | $12.6M | Buy |
|
|||||
|
2019
Q4 | $16.4M | Buy |
|
|||||
|
2019
Q3 | $18.4M | Buy |
|
|||||
|
2019
Q2 | $684K | Buy |
|